Planta Med 2006; 72(14): 1285-1289
DOI: 10.1055/s-2006-951680
Original Paper
Pharmacology
© Georg Thieme Verlag KG Stuttgart · New York

Characterization of 3α-Acetyl-11-keto-α-boswellic Acid, a Pentacyclic Triterpenoid Inducing Apoptosis in vitro and in vivo

Berthold Büchele1 , Waltraud Zugmaier1 , Aidee Estrada1 , Felicitas Genze1 , Tatiana Syrovets1 , Christian Paetz3 , Bernd Schneider2 , Thomas Simmet1
  • 1Institute of Pharmacology of Natural Products and Clinical Pharmacology, University of Ulm, Ulm, Germany
  • 2Max Planck Institute for Chemical Ecology, Department NMR/Biosynthesis, Jena, Germany
  • 3Tokushima Bunri University, Faculty of Pharmacy, Tokushima, Japan
Weitere Informationen

Publikationsverlauf

Received: October 17, 2005

Accepted: August 14, 2006

Publikationsdatum:
04. Oktober 2006 (online)

Preview

Abstract

3α-Acetyl-11-keto-α-boswellic acid (3α-acetoxy-11-oxo-olean-12-en-24-oic acid, 1) was synthesized by a radical-type reaction using bromine and 3α-acetyl-α-boswellic acid isolated from the oleo-gum-resin of Boswellia carterii. 1D and 2D NMR (COSY, HMBC, ROESY) at 500 MHz were used for shift assignments and structure verification. The compound investigated is present in a herbal preparation extracted from Boswellia serrata oleo-gum-resin, it inhibits the growth of chemotherapy-resistant human PC-3 prostate cancer cells in vitro and induces apoptosis as shown by activation of caspase 3 and the induction of DNA fragmentation. In addition, compound 1 is active in vivo as shown by inhibition of proliferation and induction of apoptosis in PC-3 prostate cancer cells xenotransplanted onto the chick chorioallantoic membrane.

References

Dr. Thomas Simmet

Institute of Pharmacology of Natural Products and Clinical Pharmacology

University of Ulm

Helmholtzstr. 20

89081 Ulm

Germany

Fax: +49-731-500-65602

eMail: thomas.simmet@uni-ulm.de